Results 21 to 30 of about 889,039 (253)

PENGARUH PENGGUNAAN BETA BLOCKER TOPIKAL JANGKA PANJANG TERHADAP SENSIBILITAS KORNEA PADA PASIEN GLAUKOMA

open access: yesJurnal Kedokteran Diponegoro, 2017
Latar Belakang : Penurunan sensibilitas kornea merupakan salah satu efek samping dari penggunaan beta blocker topikal yang dapat menimbulkan berbagai masalah seperti penurunan reflex mengedip, penurunan kemampuan penyembuhan luka pada kornea, dan terkait
Tusita Devi, Fifin Luthfia Rahmi
doaj   +1 more source

Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis

open access: yesClinical Medicine Insights: Endocrinology and Diabetes, 2022
Background: Depression is associated with lower quality of life and increased risk of mortality. The prevalence of depression in chronic dialysis patients, as well as in patients with diabetes, is more than 20%. It is debated whether use of beta-blockers
Robin Lengton   +6 more
doaj   +1 more source

Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey

open access: yesESC Heart Failure, 2021
Aims The use of beta‐blocker therapy in cardiac amyloidosis (CA) is debated. We aimed at describing patterns of beta‐blocker prescription through a nationwide survey.
Giacomo Tini   +29 more
doaj   +1 more source

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease [PDF]

open access: yes, 2012
<p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among ...
Abergel, Helene   +66 more
core   +1 more source

Pretreatment with beta-blockers and the frequency of hypokalemia in patients with acute chest pain [PDF]

open access: yes, 1987
Plasma potassium concentration was measured at admission in 1234 patients who presented with acute chest pain. One hundred and ninety five patients were on P blockers before admission.
Rodger, J.C.   +11 more
core   +4 more sources

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

open access: yesJournal of Ophthalmology, 2017
Objective. To evaluate the efficacy and tolerability of travoprost 0.004%/timolol 0.5% fixed-dose combination (TTFC) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) inadequately controlled on beta-blocker monotherapy. Methods.
Simon Fabian Lerner   +5 more
doaj   +1 more source

Efficacy of beta-blocker therapy in symptomatic athletes with exercise-induced intra-ventricular gradients

open access: yesCardiovascular Ultrasound, 2010
Background Upright exercise stress echocardiography (SE) induces significant intraventricular gradient (IVG) and systolic anterior motion (SAM) in a large proportion of symptomatic athletes, who may therefore benefit from a negative inotropic therapy ...
Cotrim Carlos   +8 more
doaj   +1 more source

The role of plasma concentrations and drug characteristics of beta‐blockers in fall risk of older persons

open access: yesPharmacology Research & Perspectives, 2023
Beta‐blocker usage is inconsistently associated with increased fall risk in the literature. However, due to age‐related changes and interindividual heterogeneity in pharmacokinetics and dynamics, it is difficult to predict which older adults are more at ...
K. J. Ploegmakers   +11 more
doaj   +1 more source

The association between beta-blocker use and chronic obstructive pulmonary disease risk, severity, and exacerbation

open access: yesMedical Journal of Babylon, 2021
Background: There is controversy about the role of beta-blockers in the number of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hemin Khalid Saber
doaj   +1 more source

THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS

open access: yesРациональная фармакотерапия в кардиологии, 2016
Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases.
S. Yu. Martsevich   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy